MK6892

MK6892
Identifiers
	IUPAC name 2-[[3-[3-(5-hydroxypyridin-2-yl)-1,2,4-oxadiazol-5-yl]-2,2-dimethylpropanoyl]amino]cyclohexene-1-carboxylic acid;
CAS Number	917910-45-3;
PubChem CID	135416394;
IUPHAR/BPS	5788;
ChemSpider	24664360;
UNII	PH9ZB6IRW0;
ChEMBL	ChEMBL1086657;
Chemical and physical data
Formula	C19H22N4O5
Molar mass	386.408 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)(CC1=NC(=NO1)C2=NC=C(C=C2)O)C(=O)NC3=C(CCCC3)C(=O)O;
	InChI InChI=1S/C19H22N4O5/c1-19(2,18(27)21-13-6-4-3-5-12(13)17(25)26)9-15-22-16(23-28-15)14-8-7-11(24)10-20-14/h7-8,10,24H,3-6,9H2,1-2H3,(H,21,27)(H,25,26); Key:CJHXBFSJXDUJHP-UHFFFAOYSA-N;

MK6892 is an experimental drug which acts as a potent and selective agonist for the Hydroxycarboxylic acid receptor 2 (GPR109A). It has been investigated for lowering blood lipid levels and potential applications in the treatment of colon cancer.^[1]^[2]^[3]^[4]

References

↑ Shen HC, Ding FX, Raghavan S, Deng Q, Luell S, Forrest MJ, et al. (March 2010). "Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate". Journal of Medicinal Chemistry. 53 (6): 2666–2670. doi:10.1021/jm100022r. PMID 20184326.
↑ Yang Y, Kang HJ, Gao R, Wang J, Han GW, DiBerto JF, et al. (March 2023). "Structural insights into the human niacin receptor HCA2-G_i signalling complex". Nature Communications. 14 (1) 1692. Bibcode:2023NatCo..14.1692Y. doi:10.1038/s41467-023-37177-6. PMC 10043007. PMID 36973264.
↑ Li N, Niu L, Liu Y, Wang Y, Su X, Xu C, et al. (May 2024). "Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses". Journal of Nanobiotechnology. 22 (1) 241. doi:10.1186/s12951-024-02506-4. PMC 11089779. PMID 38735933.
↑ Wang J, Qian Y, Han Z, Wang Y, Liu Y, Li J, et al. (February 2025). "Insights into the Activation Mechanism of HCA1, HCA2, and HCA3". Journal of Medicinal Chemistry. 68 (4): 4527–4539. doi:10.1021/acs.jmedchem.4c02567. PMC 11873900. PMID 39936872.

[1] Shen HC, Ding FX, Raghavan S, Deng Q, Luell S, Forrest MJ, et al. (March 2010). "Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate". Journal of Medicinal Chemistry. 53 (6): 2666–2670. doi:10.1021/jm100022r. PMID 20184326.

[2] Yang Y, Kang HJ, Gao R, Wang J, Han GW, DiBerto JF, et al. (March 2023). "Structural insights into the human niacin receptor HCA2-G_i signalling complex". Nature Communications. 14 (1) 1692. Bibcode:2023NatCo..14.1692Y. doi:10.1038/s41467-023-37177-6. PMC 10043007. PMID 36973264.

[3] Li N, Niu L, Liu Y, Wang Y, Su X, Xu C, et al. (May 2024). "Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses". Journal of Nanobiotechnology. 22 (1) 241. doi:10.1186/s12951-024-02506-4. PMC 11089779. PMID 38735933.

[4] Wang J, Qian Y, Han Z, Wang Y, Liu Y, Li J, et al. (February 2025). "Insights into the Activation Mechanism of HCA1, HCA2, and HCA3". Journal of Medicinal Chemistry. 68 (4): 4527–4539. doi:10.1021/acs.jmedchem.4c02567. PMC 11873900. PMID 39936872.

[1]

[2]

[3]

[4]

This page was redesigned at the edge.

A page that knows where it met you.

MK6892

References